Introduction/Background We analyzed the predictive value of the Sentinel Lymph Node Biopsy (SLNB) in order to assess its safety and reliability.
Methodology Retrospective analyses of patients diagnosed with early-stage cervical cancer (ESCC) between June 2010 and June 2017. All patients underwent SLNB followed by pelvic lymphadenectomy (PL). Stage was IA1 to IIA1.
Results 61(39,8%) met the inclusion criteria. The mean tumor size was 21.1 mm preoperatively. A 70% of the patients had a tumor size ≤2 cm. We performed 47 (77.0%) SLNB followed by bilateral PL. According to the technique we obtained bilateral detection in 30/47 patients (63,8%). Unilateral detection was observed in 12/47 cases (25,5%) and bilateral failure in 5/47 cases (10.6%). The lymph node status was positive in 4/47 cases (8.5%) in which para-aortic lymphadenectomy was accomplished for staging.
The overall detection rate of the technique was 76.6%. We found a sensitivity of 100%, a specificity of 75,5%, a negative predictive value of 100% and a false negative rate of 0%.
We observed a lymphovascular and neurological morbidity in 6.4% (3/47), and 8.5% (4/47) respectively.
Conclusion The SLNB would allow a decrease in the morbidity associated with PL.
It seems to be a trend towards a more conservative and less aggressive surgery.
Accurate selection of patients is key point.
Disclosure Nothing to disclose.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.